SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-039820
Filing Date
2023-08-08
Accepted
2023-08-08 16:13:09
Documents
73
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q atra-20230630.htm   iXBRL 10-Q 3427631
2 EX-31.1 atra-ex31_1.htm EX-31.1 17250
3 EX-31.2 atra-ex31_2.htm EX-31.2 17118
4 EX-32.1 atra-ex32_1.htm EX-32.1 12692
  Complete submission text file 0000950170-23-039820.txt   10614474

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT atra-20230630_lab.xml EX-101.LAB 499926
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT atra-20230630.xsd EX-101.SCH 69284
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT atra-20230630_cal.xml EX-101.CAL 68168
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT atra-20230630_def.xml EX-101.DEF 179846
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT atra-20230630_pre.xml EX-101.PRE 368339
67 EXTRACTED XBRL INSTANCE DOCUMENT atra-20230630_htm.xml XML 1940339
Mailing Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320
Business Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320 805-623-4244
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36548 | Film No.: 231151458
SIC: 2836 Biological Products, (No Diagnostic Substances)